Behind the Mystery: Pompe Disease
February 28, 2019
Solving the Diagnosis Challenge
Approximately one in 10 Americans suffer from a rare disease. In the U.S., a disease is considered rare if it affects fewer than 200,000 people. If you’re struggling, know you are not alone.
That’s why we’re learning about Pompe disease, a rare neuromuscular disorder affecting the hips, thighs, and shoulders, as well as muscles in the lungs. Currently, it impacts one in 40,000 births. As a result, one’s ability to move and breathe is impacted.
On The Balancing Act’s Rare Disease Day Special, we are joined by Dr. Barry Byrne, a clinician scientist whose research is focused on Pompe Disease, and a patient who lives with the disorder. We’re also joined by Sarah Gonzalez, head of medical diagnostics at Sanofi Genzyme, who discusses how genetic testing plays an important role in obtaining a diagnosis.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.